We have assembled an amazing team of scientists, clinicians and innovators in our quest to bring
remote medication monitoring to the world.
We have assembled an amazing board of advisors with valuable clinical, scientific, regulatory, technical and commercial expertise.
Chief Executive Officer
For the first part of his career Patrik worked in various start-ups, mid-sized, privately-held companies as well as large, publicly-traded companies, primarily in the B2B software and market research industries where client lists included many leading technology companies. He took on as many different roles as possible to learn about all aspects of business, always with the goal becoming an entrepreneur. After being part of six acquisitions as an employee, he was inspired to found CARI Health after watching a close family member’s struggle with opioids. Since then, he’s been leading a team of clinicians, bio-chemical and electrical engineers on a mission to build a company that will have a positive and lasting impact on the opioid crisis.
Chief Science Officer
Dr. Fiebig is a CalTech trained chemist and entrepreneur who straddles the line between academia and private industry. He has extensive expertise in analytical and biophysical chemistry, in addition to having founded several businesses. Dr. Fiebig received his Ph.D. in chemistry at the Max Planck Institute for Biophysical Chemistry, Germany.
Chief Medical Officer
Dr. Carr is a Harvard and Stanford trained physician-entrepreneur. He entered the field of addiction medicine in 2015 and serves as the Medical Director of an Outpatient Treatment Program for opioid use disorder. His prior training in Biochemical Sciences at Harvard, medical school trainings in medical informatics at Stanford Medical School, and Internal Medicine trainings at UCSF/UCSD created the basis for his pursuit of the first website for internet-based telemedicine in the United States. In the spring of 1999 he was awarded the Cybervision Award for the Homecare Extranet from the US Department of Health and Human Services. Subsequently he built a protocol engine for asynchronous telemedicine as the cofounder of Gogohealth LLC . His vision and clinical experience significantly contributed to the methadone use case for the CARI Health electrochemical sensor.
Chief Technology Officer
Adi Mandapaka is a Technology/Product Developer and Entrepreneur in the Wearables, Medical Devices and Digital Health spaces. His early career was spent learning engineering for scale at large public technology companies, before pivoting to work on his true passion – the application of technology towards improved, inexpensive health and wellness for all. His last few years have been spent involved with CGM, Wearable and Digital Health companies, trying to move the needle on better, cheaper and more connected healthcare across the globe. Adi joined the team at CARI Health as CTO to work on creating the world’s first Wearable Remote Medication Monitor.
Research Scientist
Dr. Seenivasan received his Ph.D. in Chemistry from MaduraiKamaraj University, Tamil Nadu, India. As a Postdoc at the University of Wisconsin – Madison as well as UC San Diego, Dr. Seenivasan performed the multidisciplinary innovative research in the (bio)electroanalytical and surface chemistry field focusing on scalable point-of-care sensor/biosensor development.
Operations Director
Laurie is an innovative executive with expertise implementing leading edge strategies to streamline business operations and increase profitability. She has experience in both the corporate and non-profit sectors not only in project management but also marketing, and business development. She oversees the daily operations at CARI.
Board Director
Gioia Messinger brings more than 30 years of high technology executive experience, with over two decades focused on consumer electronics, Internet of Things (IoT), robotics/artificial intelligence (AI) and digital health as Founder/CEO, board member, interim executive and venture capital advisor. Ms. Messinger is the founder and Principal of LinkedObjects, Inc., a strategic advisory services business focused on digital transformation brought about by AI and IoT. She currently is an advisor to several start-ups and serves on the board of One Stop Systems (NASDAQ:OSS) and Indyme Solutions. Ms. Messinger obtained her MBA from the Paul Merage School of Business at the University of California, Irvine and her B.S./M.A. in Computer Engineering from University of California, San Diego. She’s an inventor on 11 patents.
Board Director
Charles currently is a private investor and serves on both for-profit and not-for-profit boards. Prior, he was the lead healthcare partner at Oak Hill Capital Partners, a middle market private equity firm. He has been an investor in Accolade, Accretive Healthcare, AccentCare, Jazz Pharmaceuticals, and Align Technology among others. Other early-stage investments include Village Practice Management, Vera Whole Health, Stability Health, and Recovery One. Not-for-profit activities include serving on the boards of Bay Area Center for Arts and Technology (BAYCAT), Verity Health, the Ralph Lauren Center for Cancer Care and Prevention, and Matters Athletic. Mr. Patton earned a B.S. degree from the University of California, Berkeley and an M.B.A. from Harvard Business School.
Technical Advisor
Dr. Hall received a B.S. degree in computer engineering with honors from the University of Nevada, Las Vegas, in 2005, along with M.S. and Ph.D. degrees in electrical engineering from Stanford University in 2008 and 2012, respectively. In 2013, he joined the Jacobs School of Engineering at the University of California, San Diego, where he is currently an associate professor in the Department of Electrical and Computer Engineering and an affiliate professor in the Department of Bioengineering. He is an expert in biosensors, bioelectronics, and analog integrated circuit design.
Clinical Advisor
Over the past 10 years, Dr. Courchesne-Krak has worked in the fields of psychiatric epidemiology, neuroscience, and genetics. She integrates state-of-the art bioinformatics approaches with small- and large-scale population datasets to advance our understanding of substance use disorders (e.g., opioids, alcohol, stimulants, cannabis) and patient health. Dr. Courchesne-Krak has investigated the impact of substance use on neurodevelopment, healthcare service utilization, morbidity, and mortality among children, adults, and pregnant women. She is passionate about novel treatment strategies designed to improve patient care and health outcomes.
Surgical & Technical Consultant
Dr. Jon Wilensky is a Board Certified Plastic and Reconstructive Surgeon, whose practice is exclusively dedicated to implantable, injectable, and wearable biotechnology. He has served as a Surgical and Technical Consultant to multiple industry partners including diabetes pioneers GlySens and ViaCyte. He is also an experienced Founder and Bioentrepreneur, and holds an MBA from the Rady School of Management. He is on the active Medical Staffs of Scripps Health and Palomar Health, the latter a member of the Mayo Clinic Care Network. His passion is to radically solve the biggest problems in healthcare with disruptive, breakthrough technologies.
Technical Advisor
Mark Prausnitz is Regents’ Professor and J. Erskine Love, Jr. Chair of Chemical & Biomolecular Engineering at the Georgia Institute of Technology. He earned a BS degree from Stanford University and PhD degree from MIT, both in chemical engineering. Dr. Prausnitz and colleagues carry out research on drug delivery using microneedles, lasers, ionic liquids and other microdevices for transdermal, ocular and intracellular delivery of drugs and vaccines. Dr. Prausnitz teaches courses on engineering calculations and pharmaceuticals. He has published more than 300 journal articles, invented almost 70 US patents, and has co-founded seven start-up companies based on microneedle technologies.
Advisory Board
Clinical Advisor
Carla Marienfeld, MD, DFAPA, FASAM is board-certified in psychiatry, addiction psychiatry, and addiction medicine, and she is a Clinical Professor at the University of California San Diego. She edited two books: Motivational Interviewing for Clinical Practice and Absolute Addiction Psychiatry Review: An essential board exam study guide. She has been highly involved in education of colleagues and trainees, and she is the fellowship director for the UCSD Addiction Psychiatry Fellowship. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale, and her medical degree with honors is from Baylor College of Medicine in Houston.
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Business Advisor
Bio coming soon!
Clinical Advisor